Stay updated on Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2, indicating a new release; the Back to Top link was removed. No other core content changes detected.
    Difference
    0.6%
    Check dated 2025-09-13T16:51:05.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.6%
    Check dated 2025-09-06T14:07:57.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    29%
    Check dated 2025-08-30T11:05:36.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T03:55:16.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-08T23:26:46.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The page has been updated to reflect a lack of efficacy in a specific program and has been revised to a new version. Additionally, a future date of July 31, 2025, has been added.
    Difference
    8%
    Check dated 2025-08-01T19:04:58.000Z thumbnail image

Stay in the know with updates to Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.